Anti-PPP1R3A monoclonal antibody
Pre-made anti-PPP1R3A monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research
Go to PPP1R3A/PPP1R3A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-IP1437-Ab-1/ GM-Tg-hg-IP1437-Ab-2 | Anti-Human PPP1R3A monoclonal antibody | Human |
GM-Tg-rg-IP1437-Ab-1/ GM-Tg-rg-IP1437-Ab-2 | Anti-Rat PPP1R3A monoclonal antibody | Rat |
GM-Tg-mg-IP1437-Ab-1/ GM-Tg-mg-IP1437-Ab-2 | Anti-Mouse PPP1R3A monoclonal antibody | Mouse |
GM-Tg-cynog-IP1437-Ab-1/ GM-Tg-cynog-IP1437-Ab-2 | Anti-Cynomolgus/ Rhesus macaque PPP1R3A monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-IP1437-Ab-1/ GM-Tg-felg-IP1437-Ab-2 | Anti-Feline PPP1R3A monoclonal antibody | Feline |
GM-Tg-cang-IP1437-Ab-1/ GM-Tg-cang-IP1437-Ab-2 | Anti-Canine PPP1R3A monoclonal antibody | Canine |
GM-Tg-bovg-IP1437-Ab-1/ GM-Tg-bovg-IP1437-Ab-2 | Anti-Bovine PPP1R3A monoclonal antibody | Bovine |
GM-Tg-equg-IP1437-Ab-1/ GM-Tg-equg-IP1437-Ab-2 | Anti-Equine PPP1R3A monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-IP1437-Ab-1/ GM-Tg-hg-IP1437-Ab-2; GM-Tg-rg-IP1437-Ab-1/ GM-Tg-rg-IP1437-Ab-2; GM-Tg-mg-IP1437-Ab-1/ GM-Tg-mg-IP1437-Ab-2; GM-Tg-cynog-IP1437-Ab-1/ GM-Tg-cynog-IP1437-Ab-2; GM-Tg-felg-IP1437-Ab-1/ GM-Tg-felg-IP1437-Ab-2; GM-Tg-cang-IP1437-Ab-1/ GM-Tg-cang-IP1437-Ab-2; GM-Tg-bovg-IP1437-Ab-1/ GM-Tg-bovg-IP1437-Ab-2; GM-Tg-equg-IP1437-Ab-1/ GM-Tg-equg-IP1437-Ab-2 |
Products Name | Anti-PPP1R3A monoclonal antibody |
Format | mab |
Target Name | PPP1R3A |
Protein Sub-location | Introcelluar Protein |
Category of antibody | |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected. |
Tag | Fc |
Products description | Pre-made anti-PPP1R3A monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-IP1437-Ag-1 | Recombinant multi-species PPR3A/ PPP1R3A/ GM protein |
Target information
Target ID | GM-IP1437 |
Target Name | PPP1R3A |
Gene ID | 5506,140491,500036,703562,482411,101084864,784877,100055851 |
Gene Symbol and Synonyms | GM,PP1G,PPP1R3,PPP1R3A,RG1,RGD1561312,RGL |
Uniprot Accession | Q16821 |
Uniprot Entry Name | PPR3A_HUMAN |
Protein Sub-location | Introcelluar Protein |
Category | |
Disease | Cancer |
Gene Ensembl | ENSG00000154415 |
Target Classification | Tumor-associated antigen (TAA) |
The target: PPP1R3A, gene name: PPP1R3A, also named as GM, PP1G, PPP1R3. The glycogen-associated form of protein phosphatase-1 (PP1) derived from skeletal muscle is a heterodimer composed of a 37-kD catalytic subunit and a 124-kD targeting and regulatory subunit. This gene encodes the regulatory subunit which binds to muscle glycogen with high affinity, thereby enhancing dephosphorylation of glycogen-bound substrates for PP1 such as glycogen synthase and glycogen phosphorylase kinase. [provided by RefSeq, Jul 2008].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.